Letter to the Editor
PCSK9 administration ameliorates non alcoholic fatty disease in patients with heterozygous familial hyperlipidemia
A. Dimakopoulou, G. Sfikas, V. Athyros
Editorial
The role of lipid-lowering treatment in the secondary prevention of ischemic stroke
E. Konstantinidou, K. Tziomalos
Original Articles
The effects of atorvastatin 30 mg compared with atorvastatin 40 mg in patients with primary hyperlipidemia: a multicenter study
C.V. Rizos, E.N. Liberopoulos, E. Mpilianou, V. Kotsis, N. Tentolouris, C. Antza, I. Eleftheriadou, V. Tsimihodimos, M.S. Elisaf
Cost-benefit analysis of mediterranean diet and medication in chronic heart failure patients
Ε. Tzorovili, C. Chrysohoou, E. Bei, K. Konstantinou, A. Filippou, S. Iosifidis
Read Volume 9 here